PPP1R13L antibody
Principal name
PPP1R13L antibody
Alternative names for PPP1R13L antibody
RelA-associated inhibitor, IASPP, NKIP1, PPP1R13BL, RAI, Inhibitor of ASPP protein, NFkB-interacting protein 1, PPP1R13B-like protein
Ncbi ID
9606, NP_001135974.1, NP_006654, NP_001010836.1, NM_001010836, NM_006663, NM_001142502
Available reactivities
Available hosts
Available applications
Enzyme Immunoassay (E), Western blot / Immunoblot (WB), Immunocytochemistry/Immunofluorescence (ICC/IF), Paraffin Sections (P), ELISA (detection) (E(detection))
Background of PPP1R13L antibody
ASPP proteins (ASPP1, ASPP2 and iASPP) represent a new family of p53 binding proteins. ASPP1 and ASPP2 bind and enhance p53-mediated apoptosis. In contrast, the third member, iASPP, functionally inactivates p53. iASPP (also called protein phosphatase 1 regulatory (inhibitor) subunit 13 like protein, Inhibitor of ASPP protein, Protein iASPP, PPP1R13B-like protein and NFkappaB-interacting protein 1) plays a central role in regulation of apoptosis and transcription via its interaction with NF-kappa-B and p53/TP53 proteins. iASPP blocks transcription of HIV-1 virus by inhibiting the action of both NF-kappa-B and SP1. This protein also inhibits p53/TP53 function, possibly by preventing the association between p53/TP53 and ASPP1 or ASPP2, and therefore suppressing the subsequent activation of apoptosis. iASPP is predominantly a cytoplasmic protein (isoform 1) but can also be found in the nucleus (isoform 2). iASPP is highly expressed in heart, placenta and prostate and is weakly expressed in brain, liver, skeletal muscle, testis and peripheral blood leukocyte. The N-terminal region of isoform 1 is required for cytoplasmic localization. Defects in iASPP may be a cause of certain breast cancers and the protein is overexpressed in many patients suffering from breast carcinomas and expressing a wild-type p53/TP53 protein.
General readings
Tomoda,K., (2008) Cancer Sci. 99 (3), 615-622




















Primary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| TA319363 | PPP1R13L (780-797) antibody |
||||||
| Rabbit polyclonal anti-iASSP antibody | |||||||
![]() |
Rabbit | IgG | Aff - Purified | Can, Hu, Ms | E, P, WB |
0.1 mg /
€515.00
|
|
| OriGene Technologies, Inc. | |||||||
+1 additional image |
|||||||
| TA322477 | PPP1R13L antibody |
||||||
| Anti-PPP1R13L Rabbit Polyclonal Antibody | |||||||
![]() |
Rabbit | IgG | Purified | Hu, Ms, Rt | E, P, WB |
0.1 ml /
€335.00
|
|
| OriGene Technologies, Inc. | |||||||
+2 additional images |
|||||||
| AP05685PU-N | PPP1R13L antibody |
||||||
![]() |
Rabbit | IgG | Purified | Can, Hu, Ms | E, WB |
50 µg /
€410.00
|
|
| OriGene Technologies GmbH | |||||||
| AP07622PU-N | PPP1R13L antibody |
||||||
![]() |
Rabbit | Aff - Purified | Hu | E, ICC/IF, P, WB |
50 µg /
€425.00
|
||
| OriGene Technologies GmbH | |||||||
Mouse Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| MR216532L2V | Lenti ORF particles, Ppp1r13l (GFP-tagged) - Mouse protein phosphatase 1, regulatory (inhibitor) subunit 13 like (Ppp1r13l), 200 uL, >10^7 TU/mL |
|
![]() |
200 µl /
€1,640.00
|
|
| OriGene Technologies, Inc. | ||
| MR216532L1V | Lenti ORF particles, Ppp1r13l (Myc-DDK-tagged) - Mouse protein phosphatase 1, regulatory (inhibitor) subunit 13 like (Ppp1r13l), 200 uL, >10^7 TU/mL |
|
![]() |
200 µl /
€1,470.00
|
|
| OriGene Technologies, Inc. | ||



![WB using Anti-iASPP antibody shows detection of a band at ~100 kDa (arrowhead) corresponding to isoform 1 of iASPP in MCF7 whole cell lysates. Preincubation with immunizing peptide blocks specific band staining (data not shown). Approximately 35 ug of lysate was separated by SDS-PAGE. After blocking, the membrane was probed with the primary antibody diluted to 1:1,500. The membrane was washed and reacted with a 1:10,000 dilution of IRDye800 conjugated Gt-a-Rabbit IgG [H&L].](https://m1.acris-antibodies.com/catalog/product/cache/1/small_image/50x50/9df78eab33525d08d6e5fb8d27136e95/OriGene/600-401-926-1-W.jpg)
+1 additional image

